Karthik Ghosh, M.D.

Education

• Lady Hardinge Medical College Delhi University
• Postgraduate Institute of Medical Education & Research
• Master's degree, Clinical Research, Mayo Clinic Graduate School of Biomedical Sciences

Internship

• Lady Hardinge Medical College

Residencies

• Obstetrics and Gynecology, Postgraduate Institute of Medical Education & Research
• Internal Medicine, University of Minnesota

Fellowship

• Royal College of Physicians of Edinburgh

Certifications

• Artificial Intelligence: Implications for Business Strategy Program, MIT Sloan & MIT CSAIL Program
• Creating and Executing Strategy, Mayo Clinic/University of Minnesota Carlson School of Management
• Disruptive Innovation, University of Minnesota Carlson School of Management
• Internal Medicine, American Board of Internal Medicine
• Leadership Agility, University of Minnesota Carlson School of Management
• MBA Essentials, University of Minnesota Carlson School of Management
• Sustaining Diversity, Equity and Inclusion Efforts, University of Minnesota Carlson School of Management

Memberships

• Association of Chairs and Leaders in General Internal Medicine
• Association of Chiefs & Leaders of General Internal Medicine
• Chair, General Internal Medicine Specialty Council, Mayo Clinic
• International Clinical Practice Committee
• Undiagnosed Mass Clinic, Mayo Clinic
• Women and Medicine Commission, Society of General Internal Medicine

• Professor of Medicine, Mayo Clinic College of Medicine and Science

• Benign breast disease
• Breast cancer care
• Breast cancer risk assessment
• Breast cancer risk reduction
• Breast cancer screening
• Clinical research
• Complex medical care
• High risk breast cancer assessments

• Idiopathic granulomatous mastitis, January 2024.
• Basal cell skin cancer, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology, November 2023.
• NCCN Guidelines® Insights: Squamous cell skin cancer, Version 1.2022, December 2021.
• NCCN Guidelines® Insights: Merkel cell carcinoma, Version 1.2024, January 2024.
• Controversies in orthopaedic oncology, May 2024.